Aspen Pharmacare Limited (APNHF)

PNK: APNHF · Real-Time Price · USD

12.24

0.00 (0.00%)

At close: Apr 30, 2025, 8:00 PM

Aspen Pharmacare Income Statement

Financials in ZAR. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Revenue	44.71B	40.71B	38.61B	37.77B	38.65B	38.87B	38.31B	41.21B	35.6B
Cost of Revenue	25.25B	22.3B	20.3B	19.98B	19.31B	19.17B	18.63B	21.32B	17.7B
Gross Profit	19.45B	18.41B	18.31B	17.79B	19.33B	19.7B	19.69B	19.9B	17.9B
Operating Income	7B	7.82B	8.67B	7.07B	7.06B	4.81B	8.51B	8.32B	9B
Interest Income	999M	509M	92M	108M	141M	213M	182M	259M	300M
Pretax Income	5.71B	6.55B	8.13B	5.99B	5.6B	2.77B	6.74B	6.25B	6.1B
Net Income	4.4B	5.23B	6.49B	4.81B	4.66B	6.46B	6.04B	5.13B	4.3B
Selling & General & Admin	10.1B	4.6B	4.4B	4.92B	5.03B	5.17B	5.08B	5.51B	4.8B
Research & Development	162M	214M	433M	260M	195M	211M	111M	188M	200M
Other Expenses	2.19B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	12.46B	9.46B	9.47B	8.6B	10.37B	10.33B	9.82B	10.15B	7.7B
Interest Expense	2.23B	1.32B	765M	1.21B	1.58B	2.33B	2.16B	2.16B	2B
Selling & Marketing Expenses	6.47B	2.92B	2.92B	3.08B	3.43B	3.52B	3.47B	4.08B	3.4B
Cost & Expenses	37.71B	31.77B	29.77B	28.57B	29.68B	29.51B	28.45B	31.46B	25.4B
Income Tax Expense	1.31B	1.33B	1.65B	1.19B	991M	774M	1.12B	1.12B	1.8B
Shares Outstanding (Basic)	444.22M	444.2M	453M	456.5M	456.5M	456.4M	456.4M	456.4M	456.4M
Shares Outstanding (Diluted)	444.2M	444.2M	453M	456.5M	456.5M	456.4M	456.4M	456.4M	456.5M
EPS (Basic)	9.91	11.77	14.32	10.53	10.22	14.16	13.23	11.23	9.45
EPS (Diluted)	9.91	11.77	14.32	10.53	10.22	14.16	13.23	11.23	9.45
EBITDA	9.91B	9.67B	10.61B	8.85B	7.45B	5.85B	10.28B	9.68B	10.5B
EBIT	7.94B	7.88B	8.9B	7.19B	5.85B	4.58B	8.91B	8.41B	8.1B
Depreciation & Amortization	1.97B	1.79B	1.71B	1.65B	1.6B	1.27B	1.37B	1.27B	1.2B